Charles River Laboratories International (CRL) Total Debt Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Total Debt Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 6.97% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -2.32% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | -4.28% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 6.31% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -60.46% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -12.65% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 1.63% |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | -7.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -7.59% |
| Sep 27, 2025 | -9.40% |
| Jun 28, 2025 | -8.04% |
| Mar 29, 2025 | -2.14% |
| Dec 28, 2024 | -5.64% |
| Sep 28, 2024 | -7.03% |
| Jun 29, 2024 | -4.08% |
| Mar 30, 2024 | 6.45% |
| Dec 30, 2023 | 10.17% |
| Jul 1, 2023 | 5.81% |
| Apr 1, 2023 | 4.94% |
| Dec 31, 2022 | 12.76% |
| Sep 24, 2022 | 15.33% |
| Jun 25, 2022 | 13.08% |
| Mar 26, 2022 | 19.46% |
| Dec 25, 2021 | 16.92% |
| Sep 25, 2021 | 19.78% |
| Jun 26, 2021 | 14.31% |
| Mar 27, 2021 | 24.87% |
| Dec 26, 2020 | 20.02% |